Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/24/2025

Management of Unstable Supraventricular Tachycardia in Children

Immediate Assessment and Stabilization

  • For hemodynamically unstable pediatric patients with SVT, the American Heart Association recommends proceeding immediately to synchronized cardioversion without attempting vagal maneuvers or pharmacologic therapy first 1, 2
  • Identify hemodynamic instability by looking for signs such as hypotension or signs of shock, poor perfusion, respiratory compromise, chest pain, or acute heart failure symptoms, with a strength of evidence based on expert consensus 1, 2, 3
  • While assessing, simultaneously maintain a patent airway and assist breathing as necessary, administer high-flow oxygen, attach a cardiac monitor/defibrillator, and establish IV or IO access, as recommended by the American Heart Association 1, 2

Primary Treatment: Synchronized Cardioversion

  • Synchronized cardioversion is the definitive treatment for unstable SVT in children and achieves essentially 100% conversion rates, according to the American Heart Association 1, 2, 5
  • The initial energy for synchronized cardioversion should be 0.5-1 J/kg, with subsequent attempts increased to 2 J/kg if necessary, based on evidence from clinical studies 1, 2
  • Ensure adequate sedation/anesthesia if time permits and patient condition allows, as recommended by the American Heart Association 5

Alternative Pharmacologic Agents

  • If adenosine fails and cardioversion remains unavailable, the American Heart Association recommends considering alternative pharmacologic agents such as amiodarone 5 mg/kg IV/IO over 20-60 minutes or procainamide 15 mg/kg IV/IO over 30-60 minutes 1, 2
  • Do not routinely administer amiodarone and procainamide together, as recommended by the American Heart Association 1, 2

Critical Pitfalls to Avoid

  • Never delay cardioversion for vagal maneuvers in unstable patients, as stated by the American Heart Association 1, 2
  • Do not use AV nodal blocking agents if there is any possibility of pre-excited atrial fibrillation, as recommended by the American Heart Association 5, 6, 3

Post-Conversion Management

  • After successful cardioversion, monitor closely for reinitiation of tachycardia from post-conversion premature beats, consider antiarrhythmic medication to prevent acute recurrence, and search for and treat underlying triggers, as recommended by the American Heart Association 5, 2
  • Arrange urgent cardiology consultation for ongoing management and consideration of catheter ablation, based on evidence from clinical studies 7, 6

Special Consideration: Wide-Complex Tachycardia

  • If the QRS duration is >0.09 seconds, treat as ventricular tachycardia until proven otherwise in an unstable patient, and proceed immediately to synchronized cardioversion without attempting adenosine, as recommended by the American Heart Association 1, 2